Four new Open Calls for infectious disease research


Published November 28, 2022
Category

ISIDORe (Integrated Services for Infectious Disease Outbreak Research) is pleased to announce the launch of its preparedness programme calls for proposals for free of charge access to its state-of-the-art facilities, cutting-edge services, advanced equipment and technologies.

Topics include Respiratory pathogens, SARS-COV-2/COVID-19, Vector-borne pathogens and their vectors, and other Pathogens with epidemic potential- these calls are running on a rolling and “first come - first served” basis. Additional topics include Monkeypox (pre-application deadline: November 29) and Risk Group 4 (RG4) pathogens (pre-application deadline: February 7, 2023).

Within the ISIDORe project, Euro-BioImaging coordinates access to 19 Nodes, all providing a portfolio of Imaging services to support research on infectious diseases. Should your project in the respective research areas require or benefit from access to Imaging technologies and expertise - we are happy to advise you and connect you with the right facility and technologies for your project! (info@eurobioimaging.eu)

For more information

Visit the ISIDORe website:

https://isidore-project.eu/calls

More information on how to apply via Euro-BioImaging:

https://www.eurobioimaging.eu/infectious-diseases-research-user-access-fund-through-isidore/


More news from Euro-BioImaging

Group photo at the EU-Australian Health Research Infrastructure Symposium in Prato, 2025.

September 24, 2025

Successful Australian & European Health Research Infrastructures symposium

From September 16-19, 2025, representatives of European and Australian Health Research Infrastructures gathered at the Monash University Prato Centre in Prato, Italy. The Euro-BioImaging…

September 23, 2025

New European strategy on Research & Technology Infrastructures

The European Commission has published its new Strategy on Research & Technology Infrastructures that aims to “make the EU the best place in the…

Representative MRI images of livers.

September 16, 2025

Spotlight - Johnson Lok – Advanced Microbiome Therapeutics (AMT)

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is the most prevalent liver disease globally, yet no therapies…